Home Tags OAG 015 – August 2017

OAG 015 – August 2017 Related Content

Securing large scale events in the aftermath of terrorism

James Kelly, Chief Executive of the British Security Industry Association, looks at some of the most effective methods of securing large-scale events

Leisure beyond the leisure centre

Cheryl Hersey of Action PR highlights how the role of leisure centres are changing to become key community hubs which deliver a range of services

Bridging the digital skills gap: What can the government do?

Civica Digital Managing Director, Chris Doutney explores how the digital skills gap can be tackled and addresses some of the challenges In a recent report, the National Audit Office (NAO) warned that government departments face being unable to take advantage of the opportunities of digital transformation. The report identified three...

How can UK universities protect themselves from cybercriminals?

Robert Stoneman, analyst at GlobalData highlights why UK universities are key targets for cybercriminals and how to safeguard from an attack UK universities will find it sobering that over 4,000 Chinese universities and research institutions were also affected by the same piece of ransomware that crippled NHS IT systems last...
The Balgrist

Therapies for weak muscles

It is estimated that ten percent of the costs of health care in Switzerland (or an equivalent of 500 billion Euros per annum in the EU) being associated with lost work is related to injury or dysfunction of the musculoskeletal system Surgical and subsequent rehabilitative interventions are an important part...

Outsourced IT fail: Why government must use the cloud

Alistair Smith, Government and Public Sector Lead, Contino outlines why moving to the cloud could help government departments ditch toxic vendor relationships I’ve spent the last few years working on projects across a number of public sector organisations and have seen many of them hamstrung by legacy vendor relationships, typically...

Drug development for cancer and inflammatory disease

Sumith A Kularatne, Vice President of Research and Development at On Target Laboratories shares the research strides he has made in drug development

Follow Open Access Government